Across TCGA pan-cancer cohorts, ATP5MGP4 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ATP5MGP4 data layer.
The strongest signal is observed in cholangiocarcinoma (CHOL), where higher ATP5MGP4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ATP5MGP4 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUSC show a favorable association.
CHOL, BLCA, and ACC are the cancer types where ATP5MGP4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.